Shay Capital »

Silence Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $135k 48k 2.82
2024-03-31 $327k 15k 21.60

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Ftai Aviation SHS (FTAI)
Vor Biopharma Com New Call Option
Sable Offshore Corp Com Shs (SOC)
First Solar (FSLR)
Tesla Motors (TSLA)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads (BABA)
Agnc Invt Corp Com reit (AGNC)
Jd.com Spon Ads Cl A (JD)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Shay Capital

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Vivo Capital
Nantahala Capital Management
Frazier Life Sciences Management
Nextech Invest
Ikarian Capital
Cantor Fitzgerald, L. P.
5AM Venture Management
UBS Group
Millennium Management
Boothbay Fund Management
SG Americas Securities

View all funds holding Silence Therapeutics